PM426. Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

por Babic, I, Gorak, A, Hughes, J, Engel, M, Sellers, D, Else, P, Lufe, L, Obeid, AL, Osborne, AL, P, Le Mesurier, Pai, N, Huang, XF, K, Weston-Green
Publicado 2016